UBS Group’s Sonnet BioTherapeutics SONN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$8.26K Buy
6,659
+6,518
+4,623% +$8.08K ﹤0.01% 7638
2025
Q1
$189 Buy
141
+138
+4,600% +$185 ﹤0.01% 8576
2024
Q4
$4 Buy
+3
New +$4 ﹤0.01% 8595
2024
Q3
Sell
-500
Closed -$3.75K 8734
2024
Q2
$3.75K Buy
+500
New +$3.75K ﹤0.01% 7016
2023
Q4
Sell
-464
Closed -$10.6K 8513
2023
Q3
$10.6K Buy
+464
New +$10.6K ﹤0.01% 5953
2023
Q1
Sell
-16
Closed -$3.24K 8981
2022
Q4
$3.24K Buy
+16
New +$3.24K ﹤0.01% 8345
2022
Q3
Sell
-10
Closed -$7K 9649
2022
Q2
$7K Sell
10
-12
-55% -$8.4K ﹤0.01% 7488
2022
Q1
$21K Buy
22
+3
+16% +$2.86K ﹤0.01% 6363
2021
Q4
$19K Buy
19
+15
+375% +$15K ﹤0.01% 6798
2021
Q3
$7K Buy
+4
New +$7K ﹤0.01% 7180
2021
Q2
Sell
-2
Closed -$10K 8563
2021
Q1
$10K Hold
2
﹤0.01% 6914
2020
Q4
$13K Buy
+2
New +$13K ﹤0.01% 6271
2020
Q3
Sell
-2
Closed -$16K 7369
2020
Q2
$16K Buy
+2
New +$16K ﹤0.01% 5853
2020
Q1
Hold
0
-$2K 7207
2019
Q4
Hold
0
-$1K 6769
2019
Q3
Hold
0
6882
2019
Q1
Hold
0
-$4K 7095
2018
Q4
Hold
0
-$4K 6708
2018
Q3
Hold
0
-$9K 6658
2018
Q2
Hold
0
-$9K 6280
2018
Q1
Hold
0
6063
2017
Q4
Hold
0
-$16K 6966
2017
Q3
Hold
0
-$93K 5702
2017
Q2
Hold
0
-$3K 4330
2017
Q1
Hold
0
-$2K 6267
2016
Q4
Hold
0
6524
2015
Q4
Hold
0
-$1K 7000
2015
Q3
Hold
0
6714
2015
Q2
Hold
0
-$6K 6870
2015
Q1
Hold
0
-$3K 6120
2014
Q4
Hold
0
6519